7Baggers
 Petros Pharmaceuticals to be Delisted from Nasdaq  TipRanks Fri, 07 Nov 2025 08:00:00 GMT
 published on: 2025-11-05 04:40:00  newser.com Wed, 05 Nov 2025 10:40:00 GMT
 published on: 2025-11-03 07:53:41  newser.com Mon, 03 Nov 2025 13:53:41 GMT
 published on: 2025-11-03 04:13:18  newser.com Mon, 03 Nov 2025 10:13:18 GMT
 published on: 2025-11-02 22:15:18  newser.com Mon, 03 Nov 2025 03:15:18 GMT
 published on: 2025-11-02 13:01:49  newser.com Sun, 02 Nov 2025 18:01:49 GMT
 published on: 2025-11-02 01:46:50  newser.com Sun, 02 Nov 2025 06:46:50 GMT
 published on: 2025-11-02 01:06:29  newser.com Sun, 02 Nov 2025 06:06:29 GMT
 published on: 2025-10-31 00:09:15  newser.com Fri, 31 Oct 2025 05:09:15 GMT
 published on: 2025-10-30 06:28:53  newser.com Thu, 30 Oct 2025 11:28:53 GMT
 published on: 2025-10-28 03:19:37  newser.com Tue, 28 Oct 2025 08:19:37 GMT

Petros Pharmaceuticals
(NASDAQ:PTPI) 

PTPI stock logo

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an approved PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializ...

Founded: 2020
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic

Share this website to your friends